| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_80b213cc29d64e9a9c632a5b8825073f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0e3ca33fbb336044de363629012f3502 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-57 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-18 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-24 |
| filingDate |
1993-10-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1996-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a168309790fa32c506b3bfb19c996d96
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_74772610d7f49d9bdc887fa47203c650 |
| publicationDate |
1996-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-5510341-A |
| titleOfInvention |
Ovulation-inhibiting preparation for hormonal contraception |
| abstract |
An ovulation-inhibiting preparation for hormonal contraception, comprising two hormone constituents packed spatially separate in a packing unit intended for chronological, sequential oral administration, said constituents each comprising a plurality of daily hormone units accommodated spatially separate and individually removable in the packaging unit. The first hormone constituent consists essentially of an estrogen preparation which effects a disturbance of the follicle stimulation; the second hormone constituent consists of an estrogen preparation and a gestagen preparation in a dose at least adequate for inhibiting ovulation. The total number of daily hormone units is equal to the total number of days in the desired cycle, and the number of daily units of the first hormone constituent is less than the number of daily units of the second hormone constituent. The first hormone constituent comprises 5 to 14 daily units, and the second hormone constituent comprises 23 to 14 daily units. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7858605-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8450299-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2305266-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7320969-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7615545-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7704984-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011124611-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005143359-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008064670-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006100566-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006241091-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8415332-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010168071-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003139381-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8338396-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8680084-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008125402-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010298279-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7855190-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008132473-A1 |
| priorityDate |
1991-02-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |